Literature DB >> 1854619

Cathepsin D assay in ovarian cancer: correlation with pathological features and receptors for oestrogen, progesterone and epidermal growth factor.

G Scambia1, P Benedetti, G Ferrandina, F Battaglia, G Baiocchi, S Mancuso.   

Abstract

Using an immunoradiometric assay, Cathepsin-D (Cath-D) concentrations were measured in the cytosol of 68 normal and neoplastic human ovarian tissues. Cath-D levels were higher in malignant tumours than in normal tissue samples (P less than 0.01) and benign tumours (P less than 0.01). In six out of seven cases, metastatic deposits showed Cath-D concentrations higher than the respective primary tumours. Using 12 of 17 pmols.mg-1 protein as cut-off levels, the Cath-D status (high or low) was not related to any pathological parameter. Moreover, no correlation was found between Cath-D levels and receptors for oestrogen, progesterone and epidermal growth factor. Our results indicate that ovarian tumours produce Cath-D. Further studies are needed to evaluate whether this protein could represent a prognostic factor for this neoplasia.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1854619      PMCID: PMC1977323          DOI: 10.1038/bjc.1991.266

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  18 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Cathepsin D: an independent prognostic factor for metastasis of breast cancer.

Authors:  F Spyratos; T Maudelonde; J P Brouillet; M Brunet; A Defrenne; C Andrieu; K Hacene; A Desplaces; J Rouëssé; H Rochefort
Journal:  Lancet       Date:  1989-11-11       Impact factor: 79.321

3.  The 52-kDa estrogen-induced protein secreted by MCF7 cells is a lysosomal acidic protease.

Authors:  M Morisset; F Capony; H Rochefort
Journal:  Biochem Biophys Res Commun       Date:  1986-07-16       Impact factor: 3.575

4.  Autocrine growth stimulation of the MCF 7 breast cancer cells by the estrogen-regulated 52 K protein.

Authors:  F Vignon; F Capony; M Chambon; G Freiss; M Garcia; H Rochefort
Journal:  Endocrinology       Date:  1986-04       Impact factor: 4.736

5.  Epidermal growth factor receptor in human breast cancer: correlation with steroid hormone receptors and axillary lymph node involvement.

Authors:  F Battaglia; G Scambia; S Rossi; P B Panici; R Bellantone; G Polizzi; P Querzoli; R Negrini; S Iacobelli; F Crucitti
Journal:  Eur J Cancer Clin Oncol       Date:  1988-11

6.  Immunohistochemical distribution of the 52-kDa protein in mammary tumors: a marker associated with cell proliferation rather than with hormone responsiveness.

Authors:  M Garcia; M J Lacombe; H Duplay; V Cavailles; D Derocq; J C Delarue; B Krebs; G Contesso; H Sancho-Garnier; G Richer
Journal:  J Steroid Biochem       Date:  1987       Impact factor: 4.292

7.  In vitro degradation of extracellular matrix with Mr 52,000 cathepsin D secreted by breast cancer cells.

Authors:  P Briozzo; M Morisset; F Capony; C Rougeot; H Rochefort
Journal:  Cancer Res       Date:  1988-07-01       Impact factor: 12.701

8.  Immunoenzymatic assay of Mr 52,000 cathepsin D in 182 breast cancer cytosols: low correlation with other prognostic parameters.

Authors:  T Maudelonde; S Khalaf; M Garcia; G Freiss; J Duporte; M Benatia; H Rogier; F Paolucci; J Simony; H Pujol
Journal:  Cancer Res       Date:  1988-01-15       Impact factor: 12.701

9.  Distribution of the Mr 52,000 estrogen-regulated protein in benign breast diseases and other tissues by immunohistochemistry.

Authors:  M Garcia; G Salazar-Retana; A Pages; G Richer; J Domergue; A M Pages; G Cavalie; J M Martin; J L Lamarque; B Pau
Journal:  Cancer Res       Date:  1986-07       Impact factor: 12.701

10.  Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer.

Authors:  S M Thorpe; H Rochefort; M Garcia; G Freiss; I J Christensen; S Khalaf; F Paolucci; B Pau; B B Rasmussen; C Rose
Journal:  Cancer Res       Date:  1989-11-01       Impact factor: 12.701

View more
  6 in total

1.  Extracellular matrix components and proteolytic enzymes in uterine cervical carcinoma.

Authors:  V Bhuvarahamurthy; S Govindasamy
Journal:  Mol Cell Biochem       Date:  1995-03-09       Impact factor: 3.396

2.  Ultrasensitive, multiplexed chemoproteomic profiling with soluble activity-dependent proximity ligation.

Authors:  Gang Li; Mark A Eckert; Jae Won Chang; Jeffrey E Montgomery; Agnieszka Chryplewicz; Ernst Lengyel; Raymond E Moellering
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-07       Impact factor: 11.205

3.  Cathepsin D immunoreactivity in ovarian cancer: correlation with prognostic factors.

Authors:  P Athanassiadou; V Sakellariou; E Petrakakou; P Athanassiades; C Zerva; A Liossi; S Michalas
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

4.  Hormone receptors and cathepsin D levels in human breast epithelial cells transformed by chemical carcinogens and c-Ha-ras transfection.

Authors:  G Calaf; Q Tahin; M E Alvarado; S Estrada; T Cox; J Russo
Journal:  Breast Cancer Res Treat       Date:  1994-02       Impact factor: 4.872

5.  Cathepsin D in primary breast carcinoma: adverse prognosis is associated with expression of cathepsin D in stromal cells.

Authors:  A E O'Donoghue; D N Poller; J A Bell; M H Galea; C W Elston; R W Blamey; I O Ellis
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

6.  Immunoradiometric and immunohistochemical analysis of Cathepsin D in ovarian cancer: lack of association with clinical outcome.

Authors:  G Ferrandina; G Scambia; A Fagotti; G D'Agostino; P Benedetti Panici; A Carbone; S Mancuso
Journal:  Br J Cancer       Date:  1998-12       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.